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Unilateral or bilateral neck dissection must be considered in the treatment of laryngeal cancer 
Aim: To evaluate the prevalence of contralateral metastases in larynx cancer and distribution of 
these metastases according to lymph node levels in the neck.
Method: Retrospective longitudinal study of 272 charts from patients with squamous cell cancer of 
the larynx treated between 1996 and 2004; and we selected 104 surgical cases submitted to neck 
dissection. We evaluated the incidence of bilateral or contralateral metastases, according to the 
location and extension of the primary tumor, considering the anatomical sub-sites and the midline. 
Results: Contralateral metastases in lateral tumors were observed in 3.5% of glottic lesions and in 
26% of supraglottic lesions. Contralateral metastases were uncommon in N0 patients. Lymph nodes 
levels IIa and III were the most commonly involved in the neck.
Conclusion: In lateral glottic tumors there is no need for elective contralateral neck dissection. In 
supraglottic lesions without ipsilateral metastases, the incidence of hidden metastasis does not justify 
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INTRODUCTION
Lymph node metastases are the main prognostic 
factor in the upper air and digestive tracts, and elec-
tive neck dissection - more than a staging procedure, 
enables high rates of regional disease control1. Al-
though lymphatic drainage and the risk of metastasis 
in each anatomical site have been established, the 
indication for elective contralateral neck dissection still 
is controversial2. The extension of this dissection has 
impacts both on treatment morbidity, mortality, and 
in disease control. The goal of the present study is to 
assess the prevalence and location of lymph node me-
tastases in laryngeal tumors, according to primary tumor 
extension, considering the indication of contralateral 
neck dissection.
MATERIALS AND METHODS
We reviewed the chart from 272 patients with 
laryngeal epidermoid carcinoma, consecutively seen 
between January of 1996 and December of 2004, 
including 104 patients submitted to surgical treatment 
with neck dissection. We did 161 neck dissections - 65 
were complete and 96 were selective. Primary tumor 
extension was determined based on the intraoperative 
descriptions, considering the anatomical sub-sites invol-
ved and their relationship with the median line. Thus, 
the lesions were classified into two groups: lesions 
with their center in the median line and lateralized 
lesions, the latter were further divided according to 
their relationship with the median line. We conside-
red the lymph node levels involved in the pathology 
exam, according to the classification from the American 
Head and Neck Society, as well as the isolated regional 
recurrences which may eventually occur. The lymph 
node level classification was done by a surgeon of the 
team, immediately after the procedure, and they were 
sent separately for histological analysis. All the patients 
were re-staged according to the TNM-2002 classification 
from the UICC-AJCC, considering the physical exam 
upon admission. The statistical analysis used descriptive 
methods and the qualitative analysis used the Fisher’s 
Exact Test, considering significant those differences with 
an alpha error lower than 5%.
RESULTS
The mean age was 56 years (36 to 79) - 86 males 
and 18 females. As to the anatomical subsite: 66 lesions 
were glottic, of which 40 were transglottic, 35 supra-
glottic and three were extensive lesions with unidenti-
fied site of origin. As far as staging is concerned, three 
patients were in stage I; 19 in stage II; 45 in stage III 
and 37 in stage IV. The mean follow up of asymptomatic 
patients was 58 months, and only six cases had less 
than one year of follow up.
Among the 104 cases, 53 (50,96%) had histologi-
cally confirmed metastases. Bilateral metastases happe-
ned in 22 (21%) cases. Primary tumors with epicenter 
in the median line or extensive tumors involving the 
entire organ, added to 28 cases; 15 (53%) with bilateral 
metastases. In the 76 cases of lateralized tumors, there 
were bilateral metastases in seven (9%) - and hidden in 
four cases. There was no case of isolated contralateral 
metastasis.
In the 76 cases of lateralized lesions, only 29 were 
submitted to bilateral dissection. Of the 47 remaining 
patients, 12 underwent postoperative radiotherapy, 
including the contralateral neck. There were two (3%) 
cases of bilateral metastases in 59 NO patients; and five 
(29%) cases among the 17 N+ patients (p=0.005).
Among the 57 patients with lateralized glottic 
lesions, there were two cases (3%) of bilateral 
metastases, both clinically identified. Among the 19 
patients with lateralized lesions in the supraglottis, we 
observed bilateral metastases in five (26%), p=0.009; and 
only one was found upon physical exam. The epiglottis 
was involved in 15 of these patients, and all five patients 
with bilateral metastases had epiglottis involvement. 
There were nine neck recurrences, with only one case 
in which the contralateral neck was not dissected.
The T staging did not significantly influence 
the presence of bilateral metastases in the lateralized 
tumors. We found bilateral metastases in 1/19 (5%) of 
the T1 and T2 cases and in 6/57 (10%) of the T3 and 
T4 cases; p=0.67.
The metastases were predominantly in levels II 
and III (Table 1). Level IV metastases were found in three 
cases; however, level IV was not routinely separated 
from the surgical specimen and is underappreciated in 
this sample.
Table 1. Lymph node levels involved according to the type of 
neck dissection (n=104).
Neck Dissection
Level Elective* Therapeutic# Total
I 1 2 3
IIa 29 29 58
IIb 1 2 3
III 11 21 32
IV 3 3 6
V 0 4 4
* 117 dissections in one side of the neck - N0.
# 44 dissections in one side of the neck - N+.
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DISCUSSION
The low morbidity of the selective dissection 
enabled us to broaden the indication for elective 
dissection, although the bilateral neck dissection may 
multiply the risk of complications with the exposure 
of both neck vessel-nervous bundles. In this series, 
approximately 50% of the patients were submitted to 
a contralateral elective dissection. Neck dissection and 
post-operative radiotherapy yielded regional disease 
control in most of the cases, which prompts for a 
discussion about overtreatment possibilities. Glottic le-
sions, including the transglottic, have a low prevalence 
of contralateral metastases, even if the primary tumor 
goes beyond the mid line. The results of the present 
study are similar to the ones reported by Marks et al.2. 
In supraglottis tumors, involvement of the central region 
established a high risk of contralateral metastases. In 
these cases, the incidence of contralateral metastases in 
lateralized lesions is higher than 20%, but are infrequent 
in the absence of ipsilateral metastases3,4. The ipsilateral 
pathological staging (pN) is even more reliable vis-à-vis 
the risk of contralateral metastases. Almost half of the 
patients with supraglottic tumors had central tumors, 
such a situation that requires bilateral treatment. In late-
ralized lesions, when there are histologically confirmed 
metastases in the ipsilateral side, contralateral metastases 
happen in up to 48% of the cases, while in stages I and 
II this frequency is of only 5%5,6.
Although the T staging (TNM - UICC/AJCC) is 
very important in the definition of the risk of ipsilateral 
metastases, its relationship with the risk of contralateral 
metastases seems to be indirect, considering that the 
tumor size is associated to the possibility of reaching 
areas (anatomical subsites) with crossed lymphatic 
drainage. In the present study, the T stage alone did 
not prove applicable in indicating contralateral elective 
dissection - a result which was also observed by other 
authors in supraglottic tumors7,8.
The possibility of postoperative radiotherapy, 
especially when the characteristics of the primary tumor 
and ipsilateral metastases would justify the adjuvant 
treatment, also deserves to be considered in relation 
to its use in the treatment of the contralateral neck. 
Although the efficacy of radiotherapy in the treatment 
of subclinical regional disease is an indirect evidence, 
the results are in favor of its use in this context1,4,9. Ba-
sed on principles, the initial treatment must be sized in 
order to completely treat the disease, while the adjuvant 
treatment may be used for areas of a greater risk of 
recurrence, acknowledging that the advanced disease 
requires a combined treatment. Elective dissection is 
usually indicated when the risk of hidden metastases 
is higher than 20%; nonetheless, since in laryngeal sur-
gery both jugular and carotid bundles are exposed, a 
dissection of opportunity may be indicated in situations 
in which the risk of metastasis is lower10. By the same 
token: comorbidities, the ease of patient follow up and 
the speed of rescue of a regional recurrence must also 
influence the decision to surgically treat the contralateral 
side. Some recurrences already present themselves as 
non-resectable disease and elective dissection provides 
the best regional control4,6,11-13. The results from the 
present study have shown that approximately 40% of 
the elective contralateral dissections, especially in NO 
supraglottic or glottic tumors, could be avoided without 
impairing the staging, since they proved to be pN0, but 
it is not possible to establish if the omission in neck 
dissection could affect the excellent result obtained in 
the regional disease control or even patient survival4,13. 
We cannot disregard that in the routine pathology as-
sessment there may be 8% false pN0, since one single 
cut in the lymph node fails to detect micrometastasis14.
As to the extension of the dissection, the 
metastases are concentrated in levels IIa and III, which 
represent the first drainage stage of these tumors, ena-
bling a super-selective dissection only of these levels 
in a negative neck8,15-17. Isolated metastases outside of 
this level are rare, and happen in only around 1% of 
the cases.
CONCLUSION
We concluded that there is a greater likelihood 
of bilateral metastasis in extensive tumors with invol-
vement of the entire organ or with its epicenter in the 
median line. Glottic tumors have low frequency of 
metastases, regardless of crossing the mid line. In cases 
of lateralized tumors, the presence of N+ neck and the 
involvement of the epiglottis were significant in the 
presence of bilateral metastases.
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